Top defibrillator Companies in 2025

The global defibrillator market is projected to grow from USD 11.99 billion in 2025 to USD 16.44 billion by 2030, registering a CAGR of 6.5% during the forecast period. Market growth is driven by the rising incidence of cardiac arrest among patients with cardiovascular diseases, increasing government and private initiatives to install defibrillators in public spaces for improved emergency response, and expanding training and awareness programs related to defibrillator use. Additionally, advancements in subcutaneous implantable cardioverter-defibrillators (S-ICDs), MRI-compatible ICDs and CRT-Ds, along with the ongoing enhancement of healthcare infrastructure in emerging economies, are expected to further fuel market expansion.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549

MEDTRONIC: Due to its extensive product portfolio, Medtronic is the leading player in the global implantable defibrillator market. The company primarily focuses on developing innovative products to treat and manage heart failure and heart rhythm disorders. The company focuses on inorganic business growth strategies such as product development & commercialization, acquisitions, and market expansions to strengthen its current position and gain a larger share of the neurovascular devices market. The company received the CE Mark for its implantable defibrillator systems, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan for managing irregular heart rhythms. Moreover, the company is also focusing on expanding its R&D capabilities to fuel product development and commercialization across mature and emerging markets.

Koninklijke Philips N.V. is a key player in the global defibrillator market, driven by its widely adopted HeartStart AED series. The company has established a strong presence through user-friendly, reliable devices designed for both public and professional use. Philips continues to lead with innovations such as real-time guidance, fast shock delivery, and connected care capabilities. Its strategic focus on accessibility, digital integration, and global deployment has reinforced its role in advancing out-of-hospital cardiac care.

Boston Scientific Corporation focuses on innovation and product launches in cardiac rhythm management to provide advanced solutions to healthcare professionals to improve the quality of life. The company continuously invests in R&D to launch new & innovative products. Boston Scientific primarily pursues the strategy of new product launches to sustain its position in the global defibrillators market. Regulatory approvals for its MRI-compatible defibrillators and technological advancements are expected to help the company maintain its position in the market.

Market Ranking:

The global defibrillator market is consolidated in nature, with the top players—Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), NIHON KOHDEN CORPORATION (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea). The competition among leading players is high, and a majority of them focus on establishing partnerships. The market is dominated by key players with a strong global footprint and well-established supply and distribution chains in developed regions such as North America and Europe. Smaller players strive for sustainable growth by focusing on low-price products and technological innovation. This results in a highly competitive market with numerous small and medium-sized players in developed and emerging markets. Meanwhile, the dominant market players leverage their expertise, higher R&D budgets, and strong brand recognition to minimize competition from smaller players in regional markets.